转移性骨病的消融与骨增强治疗以实现局部肿瘤控制:一篇叙述性综述
本文综述了介入肿瘤学中热消融技术(射频消融、微波消融、冷冻消融及高强度聚焦超声)联合骨增强技术(标准或强化骨成形术)治疗转移性骨病的病理生理、技术 repertoire、临床结局与未来方向,强调治疗意图、疾病生物学及并发症风险影响疗效,需细致术前规划。
要点
- 热消融联合骨增强技术可实现转移性骨病的局部肿瘤控制和疼痛缓解。
- 治疗意图(治愈或姑息)及疾病生物学影响疗效,需个体化规划。
- 热损伤周围组织等并发症风险要求 meticulous 的术前规划。
核心结论
- 热消融联合骨增强技术是转移性骨病的有前景的微创治疗方法,可实现局部肿瘤控制和疼痛缓解,但需考虑疾病生物学、治疗意图和并发症风险进行细致规划。
研究设计与样本
- 叙述性综述,总结了热消融技术及骨增强技术治疗转移性骨病的病理生理、临床结局和未来方向。
临床应用与阅片要点
- 作者指出,热消融联合骨增强技术可获得良好的局部肿瘤控制和疼痛缓解,同时通过骨增强确保结构稳定性;治疗规划需考虑疾病生物学、治疗意图(治愈或姑息)及热损伤等并发症风险。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Interventional oncology has gained a lot of traction as an attractive alternative treatment for various musculoskeletal tumours by offering minimally invasive image-guided therapies. In this domain, thermal ablation is increasingly being used malignant tumours, including bone metastatic disease. Thermal ablation therapies such as radiofrequency ablation, microwave ablation, cryoablation and high intensity focused ultrasound therapy achieve excellent local tumour control and pain palliation, whilst structural stability is ensured through the combination with bone augmentation techniques such as standard or reinforced osteoplasty. Many factors are affecting the results including the biology of the disease the treatment intent (curative or palliative) as well as the potential for complications, like thermal injury to surrounding tissues, highlight the need for meticulous procedural planning. This review highlights the pathophysiology, the current repertoire of thermal ablation techniques, clinical outcomes and the future directions for the treatment of metastatic bone disease.
引用
- Chlorogiannis DD, Koumadoraki E, Stouras I, et al. Metastatic bone disease ablation and augmentation for local tumour control: a narrative review. Br J Radiol. 2026. PMID: 41530106. doi:10.1093/bjr/tqag010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。